nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.146	0.185	CbGbCtD
Methoxsalen—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0957	0.121	CbGbCtD
Methoxsalen—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0592	0.075	CbGbCtD
Methoxsalen—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0556	0.0705	CbGbCtD
Methoxsalen—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0556	0.0705	CbGbCtD
Methoxsalen—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0503	0.0638	CbGbCtD
Methoxsalen—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0421	0.0535	CbGbCtD
Methoxsalen—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0381	0.0483	CbGbCtD
Methoxsalen—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.031	0.0393	CbGbCtD
Methoxsalen—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0291	0.037	CbGbCtD
Methoxsalen—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0291	0.037	CbGbCtD
Methoxsalen—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0264	0.0334	CbGbCtD
Methoxsalen—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0264	0.0334	CbGbCtD
Methoxsalen—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0227	0.0289	CbGbCtD
Methoxsalen—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0221	0.028	CbGbCtD
Methoxsalen—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.02	0.0253	CbGbCtD
Methoxsalen—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.02	0.0253	CbGbCtD
Methoxsalen—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0191	0.0243	CbGbCtD
Methoxsalen—CYP2A13—lung—acquired immunodeficiency syndrome	0.00112	0.237	CbGeAlD
Methoxsalen—Malaise—Nelfinavir—acquired immunodeficiency syndrome	0.000732	0.00354	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000721	0.00348	CcSEcCtD
Methoxsalen—Malaise—Abacavir—acquired immunodeficiency syndrome	0.000719	0.00348	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000716	0.00346	CcSEcCtD
Methoxsalen—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.000716	0.00346	CcSEcCtD
Methoxsalen—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000705	0.00341	CcSEcCtD
Methoxsalen—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000703	0.0034	CcSEcCtD
Methoxsalen—Depression—Ritonavir—acquired immunodeficiency syndrome	0.000698	0.00337	CcSEcCtD
Methoxsalen—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00069	0.00334	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.00069	0.00333	CcSEcCtD
Methoxsalen—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000689	0.00333	CcSEcCtD
Methoxsalen—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000684	0.00331	CcSEcCtD
Methoxsalen—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.000683	0.0033	CcSEcCtD
Methoxsalen—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000683	0.0033	CcSEcCtD
Methoxsalen—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.000676	0.00327	CcSEcCtD
Methoxsalen—Depression—Saquinavir—acquired immunodeficiency syndrome	0.000672	0.00325	CcSEcCtD
Methoxsalen—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.000671	0.00324	CcSEcCtD
Methoxsalen—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00067	0.00324	CcSEcCtD
Methoxsalen—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000664	0.00321	CcSEcCtD
Methoxsalen—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000663	0.0032	CcSEcCtD
Methoxsalen—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.000653	0.00316	CcSEcCtD
Methoxsalen—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000651	0.00315	CcSEcCtD
Methoxsalen—Infection—Abacavir—acquired immunodeficiency syndrome	0.000646	0.00313	CcSEcCtD
Methoxsalen—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000644	0.00311	CcSEcCtD
Methoxsalen—Tension—Indinavir—acquired immunodeficiency syndrome	0.000642	0.0031	CcSEcCtD
Methoxsalen—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000642	0.0031	CcSEcCtD
Methoxsalen—Depression—Lamivudine—acquired immunodeficiency syndrome	0.000641	0.0031	CcSEcCtD
Methoxsalen—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000641	0.0031	CcSEcCtD
Methoxsalen—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.000635	0.00307	CcSEcCtD
Methoxsalen—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.000634	0.00307	CcSEcCtD
Methoxsalen—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.000634	0.00307	CcSEcCtD
Methoxsalen—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000632	0.00306	CcSEcCtD
Methoxsalen—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000632	0.00306	CcSEcCtD
Methoxsalen—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000629	0.00304	CcSEcCtD
Methoxsalen—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.00299	CcSEcCtD
Methoxsalen—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000608	0.00294	CcSEcCtD
Methoxsalen—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000607	0.00293	CcSEcCtD
Methoxsalen—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000607	0.00293	CcSEcCtD
Methoxsalen—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000605	0.00293	CcSEcCtD
Methoxsalen—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000601	0.00291	CcSEcCtD
Methoxsalen—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.0006	0.0029	CcSEcCtD
Methoxsalen—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000599	0.0029	CcSEcCtD
Methoxsalen—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000597	0.00289	CcSEcCtD
Methoxsalen—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000592	0.00286	CcSEcCtD
Methoxsalen—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.00286	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000591	0.00286	CcSEcCtD
Methoxsalen—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00059	0.00285	CcSEcCtD
Methoxsalen—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00059	0.00285	CcSEcCtD
Methoxsalen—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000589	0.00285	CcSEcCtD
Methoxsalen—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000588	0.00284	CcSEcCtD
Methoxsalen—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000583	0.00282	CcSEcCtD
Methoxsalen—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000581	0.00281	CcSEcCtD
Methoxsalen—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00058	0.00281	CcSEcCtD
Methoxsalen—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000579	0.0028	CcSEcCtD
Methoxsalen—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000574	0.00278	CcSEcCtD
Methoxsalen—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000574	0.00278	CcSEcCtD
Methoxsalen—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000573	0.00277	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000572	0.00277	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00057	0.00276	CcSEcCtD
Methoxsalen—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000569	0.00275	CcSEcCtD
Methoxsalen—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000564	0.00273	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000562	0.00272	CcSEcCtD
Methoxsalen—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000561	0.00271	CcSEcCtD
Methoxsalen—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.0027	CcSEcCtD
Methoxsalen—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000557	0.00269	CcSEcCtD
Methoxsalen—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000555	0.00268	CcSEcCtD
Methoxsalen—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00055	0.00266	CcSEcCtD
Methoxsalen—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000549	0.00265	CcSEcCtD
Methoxsalen—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000546	0.00264	CcSEcCtD
Methoxsalen—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000543	0.00263	CcSEcCtD
Methoxsalen—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000541	0.00261	CcSEcCtD
Methoxsalen—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000538	0.0026	CcSEcCtD
Methoxsalen—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000537	0.00259	CcSEcCtD
Methoxsalen—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000536	0.00259	CcSEcCtD
Methoxsalen—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000536	0.00259	CcSEcCtD
Methoxsalen—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000534	0.00258	CcSEcCtD
Methoxsalen—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000533	0.00258	CcSEcCtD
Methoxsalen—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000531	0.00257	CcSEcCtD
Methoxsalen—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000531	0.00257	CcSEcCtD
Methoxsalen—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.00254	CcSEcCtD
Methoxsalen—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000526	0.00254	CcSEcCtD
Methoxsalen—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000526	0.00254	CcSEcCtD
Methoxsalen—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000526	0.00254	CcSEcCtD
Methoxsalen—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000526	0.00254	CcSEcCtD
Methoxsalen—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000525	0.00254	CcSEcCtD
Methoxsalen—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000524	0.00253	CcSEcCtD
Methoxsalen—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000523	0.00253	CcSEcCtD
Methoxsalen—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000522	0.00252	CcSEcCtD
Methoxsalen—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00052	0.00251	CcSEcCtD
Methoxsalen—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000519	0.00251	CcSEcCtD
Methoxsalen—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000519	0.00251	CcSEcCtD
Methoxsalen—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000517	0.0025	CcSEcCtD
Methoxsalen—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.00249	CcSEcCtD
Methoxsalen—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000514	0.00249	CcSEcCtD
Methoxsalen—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000507	0.00245	CcSEcCtD
Methoxsalen—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.00245	CcSEcCtD
Methoxsalen—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000505	0.00244	CcSEcCtD
Methoxsalen—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000504	0.00244	CcSEcCtD
Methoxsalen—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.00243	CcSEcCtD
Methoxsalen—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000497	0.0024	CcSEcCtD
Methoxsalen—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000496	0.0024	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000496	0.0024	CcSEcCtD
Methoxsalen—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000493	0.00238	CcSEcCtD
Methoxsalen—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000493	0.00238	CcSEcCtD
Methoxsalen—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000492	0.00238	CcSEcCtD
Methoxsalen—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000491	0.00238	CcSEcCtD
Methoxsalen—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.00237	CcSEcCtD
Methoxsalen—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000488	0.00236	CcSEcCtD
Methoxsalen—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000488	0.00236	CcSEcCtD
Methoxsalen—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000488	0.00236	CcSEcCtD
Methoxsalen—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000487	0.00235	CcSEcCtD
Methoxsalen—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000484	0.00234	CcSEcCtD
Methoxsalen—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000483	0.00233	CcSEcCtD
Methoxsalen—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.00233	CcSEcCtD
Methoxsalen—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000483	0.00233	CcSEcCtD
Methoxsalen—Rash—Didanosine—acquired immunodeficiency syndrome	0.00048	0.00232	CcSEcCtD
Methoxsalen—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00232	CcSEcCtD
Methoxsalen—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000479	0.00232	CcSEcCtD
Methoxsalen—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000479	0.00232	CcSEcCtD
Methoxsalen—Headache—Didanosine—acquired immunodeficiency syndrome	0.000477	0.0023	CcSEcCtD
Methoxsalen—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.00229	CcSEcCtD
Methoxsalen—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.00229	CcSEcCtD
Methoxsalen—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000473	0.00229	CcSEcCtD
Methoxsalen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00047	0.00227	CcSEcCtD
Methoxsalen—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00227	CcSEcCtD
Methoxsalen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000469	0.00227	CcSEcCtD
Methoxsalen—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000467	0.00226	CcSEcCtD
Methoxsalen—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000466	0.00225	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000461	0.00223	CcSEcCtD
Methoxsalen—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00046	0.00223	CcSEcCtD
Methoxsalen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00046	0.00222	CcSEcCtD
Methoxsalen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000456	0.00221	CcSEcCtD
Methoxsalen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.0022	CcSEcCtD
Methoxsalen—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000454	0.00219	CcSEcCtD
Methoxsalen—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00219	CcSEcCtD
Methoxsalen—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000452	0.00218	CcSEcCtD
Methoxsalen—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000451	0.00218	CcSEcCtD
Methoxsalen—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000451	0.00218	CcSEcCtD
Methoxsalen—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.00216	CcSEcCtD
Methoxsalen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00215	CcSEcCtD
Methoxsalen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000443	0.00214	CcSEcCtD
Methoxsalen—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00213	CcSEcCtD
Methoxsalen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000438	0.00212	CcSEcCtD
Methoxsalen—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000437	0.00211	CcSEcCtD
Methoxsalen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000437	0.00211	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000436	0.00211	CcSEcCtD
Methoxsalen—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.0021	CcSEcCtD
Methoxsalen—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000433	0.0916	CbGeAlD
Methoxsalen—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00209	CcSEcCtD
Methoxsalen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00208	CcSEcCtD
Methoxsalen—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00043	0.00208	CcSEcCtD
Methoxsalen—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00043	0.00208	CcSEcCtD
Methoxsalen—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000429	0.00207	CcSEcCtD
Methoxsalen—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00206	CcSEcCtD
Methoxsalen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00205	CcSEcCtD
Methoxsalen—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000424	0.00205	CcSEcCtD
Methoxsalen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.00204	CcSEcCtD
Methoxsalen—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000422	0.00204	CcSEcCtD
Methoxsalen—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000418	0.00202	CcSEcCtD
Methoxsalen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.00202	CcSEcCtD
Methoxsalen—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00202	CcSEcCtD
Methoxsalen—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.00202	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000417	0.00201	CcSEcCtD
Methoxsalen—Rash—Stavudine—acquired immunodeficiency syndrome	0.000416	0.00201	CcSEcCtD
Methoxsalen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000416	0.00201	CcSEcCtD
Methoxsalen—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.00201	CcSEcCtD
Methoxsalen—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000415	0.00201	CcSEcCtD
Methoxsalen—Headache—Stavudine—acquired immunodeficiency syndrome	0.000414	0.002	CcSEcCtD
Methoxsalen—Rash—Abacavir—acquired immunodeficiency syndrome	0.00041	0.00198	CcSEcCtD
Methoxsalen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00041	0.00198	CcSEcCtD
Methoxsalen—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00041	0.00198	CcSEcCtD
Methoxsalen—Headache—Abacavir—acquired immunodeficiency syndrome	0.000408	0.00197	CcSEcCtD
Methoxsalen—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00197	CcSEcCtD
Methoxsalen—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000406	0.00196	CcSEcCtD
Methoxsalen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00196	CcSEcCtD
Methoxsalen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000404	0.00195	CcSEcCtD
Methoxsalen—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000401	0.00194	CcSEcCtD
Methoxsalen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.00194	CcSEcCtD
Methoxsalen—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00193	CcSEcCtD
Methoxsalen—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.00192	CcSEcCtD
Methoxsalen—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.00192	CcSEcCtD
Methoxsalen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000394	0.0019	CcSEcCtD
Methoxsalen—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000393	0.0019	CcSEcCtD
Methoxsalen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.0019	CcSEcCtD
Methoxsalen—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000392	0.0019	CcSEcCtD
Methoxsalen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000389	0.00188	CcSEcCtD
Methoxsalen—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000386	0.00187	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000385	0.00186	CcSEcCtD
Methoxsalen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.00185	CcSEcCtD
Methoxsalen—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00185	CcSEcCtD
Methoxsalen—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000382	0.00184	CcSEcCtD
Methoxsalen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00038	0.00184	CcSEcCtD
Methoxsalen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00183	CcSEcCtD
Methoxsalen—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00183	CcSEcCtD
Methoxsalen—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.0018	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000371	0.00179	CcSEcCtD
Methoxsalen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000371	0.00179	CcSEcCtD
Methoxsalen—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.00178	CcSEcCtD
Methoxsalen—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00175	CcSEcCtD
Methoxsalen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00175	CcSEcCtD
Methoxsalen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00174	CcSEcCtD
Methoxsalen—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00174	CcSEcCtD
Methoxsalen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00173	CcSEcCtD
Methoxsalen—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00172	CcSEcCtD
Methoxsalen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00171	CcSEcCtD
Methoxsalen—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00171	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000354	0.00171	CcSEcCtD
Methoxsalen—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000353	0.00171	CcSEcCtD
Methoxsalen—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00171	CcSEcCtD
Methoxsalen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00165	CcSEcCtD
Methoxsalen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00165	CcSEcCtD
Methoxsalen—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000341	0.00165	CcSEcCtD
Methoxsalen—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00164	CcSEcCtD
Methoxsalen—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.00163	CcSEcCtD
Methoxsalen—Rash—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00163	CcSEcCtD
Methoxsalen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00163	CcSEcCtD
Methoxsalen—Headache—Indinavir—acquired immunodeficiency syndrome	0.000334	0.00162	CcSEcCtD
Methoxsalen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00161	CcSEcCtD
Methoxsalen—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00159	CcSEcCtD
Methoxsalen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00157	CcSEcCtD
Methoxsalen—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00157	CcSEcCtD
Methoxsalen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.00154	CcSEcCtD
Methoxsalen—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00154	CcSEcCtD
Methoxsalen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00154	CcSEcCtD
Methoxsalen—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000317	0.00153	CcSEcCtD
Methoxsalen—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00153	CcSEcCtD
Methoxsalen—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.00153	CcSEcCtD
Methoxsalen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00153	CcSEcCtD
Methoxsalen—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000313	0.0663	CbGeAlD
Methoxsalen—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Methoxsalen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Methoxsalen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Methoxsalen—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00146	CcSEcCtD
Methoxsalen—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00146	CcSEcCtD
Methoxsalen—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00145	CcSEcCtD
Methoxsalen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.00143	CcSEcCtD
Methoxsalen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.0014	CcSEcCtD
Methoxsalen—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00139	CcSEcCtD
Methoxsalen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00137	CcSEcCtD
Methoxsalen—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00136	CcSEcCtD
Methoxsalen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00136	CcSEcCtD
Methoxsalen—CYP2A6—vagina—acquired immunodeficiency syndrome	0.00028	0.0592	CbGeAlD
Methoxsalen—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00135	CcSEcCtD
Methoxsalen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00131	CcSEcCtD
Methoxsalen—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00131	CcSEcCtD
Methoxsalen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00131	CcSEcCtD
Methoxsalen—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.0013	CcSEcCtD
Methoxsalen—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00128	CcSEcCtD
Methoxsalen—CYP2A6—lung—acquired immunodeficiency syndrome	0.000265	0.056	CbGeAlD
Methoxsalen—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00125	CcSEcCtD
Methoxsalen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00125	CcSEcCtD
Methoxsalen—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00124	CcSEcCtD
Methoxsalen—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00123	CcSEcCtD
Methoxsalen—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00118	CcSEcCtD
Methoxsalen—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000205	0.0434	CbGeAlD
Methoxsalen—CYP2A6—brain—acquired immunodeficiency syndrome	0.000187	0.0396	CbGeAlD
Methoxsalen—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000166	0.0352	CbGeAlD
Methoxsalen—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000164	0.0347	CbGeAlD
Methoxsalen—CYP1A2—blood—acquired immunodeficiency syndrome	0.000159	0.0335	CbGeAlD
Methoxsalen—CYP1A1—blood—acquired immunodeficiency syndrome	0.000156	0.0331	CbGeAlD
Methoxsalen—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000145	0.0307	CbGeAlD
Methoxsalen—CYP1A2—lung—acquired immunodeficiency syndrome	0.000139	0.0294	CbGeAlD
Methoxsalen—CYP1A1—lung—acquired immunodeficiency syndrome	0.000137	0.029	CbGeAlD
Methoxsalen—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000127	0.0269	CbGeAlD
Methoxsalen—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000122	0.0259	CbGeAlD
Methoxsalen—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00012	0.0255	CbGeAlD
Methoxsalen—CYP3A4—blood—acquired immunodeficiency syndrome	0.000115	0.0243	CbGeAlD
Methoxsalen—CYP1A1—brain—acquired immunodeficiency syndrome	9.71e-05	0.0205	CbGeAlD
Methoxsalen—CYP1A1—lymph node—acquired immunodeficiency syndrome	9.38e-05	0.0198	CbGeAlD
Methoxsalen—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.32e-05	0.0197	CbGeAlD
Methoxsalen—CYP3A4—central nervous system—acquired immunodeficiency syndrome	8.97e-05	0.019	CbGeAlD
